Cited by 972Cancer-related Molecular PathwaysDNA Repair MechanismsHeat shock proteins research

The DOI matches its Crossref record; 78 of the 84 references it cites were found in a registry or an index.

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Open access

Shieh, Sheau-Yann, Ahn, Jinwoo, Tamai, Katsuyuki, Taya, Yoichi, Prives, Carol·2000·Genes & Development

Open this paper in CoChat — free account Open PDF

Abstract

Upon DNA damage, the amino terminus of p53 is phosphorylated at a number of serine residues including S20, a site that is particularly important in regulating stability and function of the protein. Because no known kinase has been identified that can modify this site, HeLa nuclear extracts were fractionated and S20 phosphorylation was followed. We discovered that a S20 kinase activity copurifies with the human homolog of the Schizosaccharomyces pombe checkpoint kinase, Chk1 (hCHK1). We confirmed that recombinant hCHK1, but not a kinase-defective version of hCHK1, can phosphorylate p53 in vitro at S20. Additional inducible amino- and carboxy-terminal sites in p53 are also phosphorylated by hCHK1, indicating that this is an unusually versatile protein kinase. It is interesting that hCHK1 strongly prefers tetrameric to monomeric p53 in vitro, consistent with our observation that phosphorylation of amino-terminal sites in vivo requires that p53 be oligomeric. Regulation of the levels and activity of hCHK1 in transfected cells is directly correlated with the levels of p53; expression of either a kinase-defective hCHK1 or antisense hCHK1 leads to reduced levels of cotransfected p53, whereas overexpression of wild-type hCHK1 or the kinase domain of hCHK1 results in increased levels of expressed p53 protein. The human homolog of the second S. pombe checkpoint kinase, Cds1 (CHK2/hCds1), phosphorylates tetrameric p53 but not monomeric p53 in vitro at sites similar to those phosphorylated by hCHK1 kinase, suggesting that both checkpoint kinases can play roles in regulating p53 after DNA damage.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.14.3.289

Cites

78 of 78 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Another p53 target gene, MDM2, encodes a p53-binding protein that negatively regulates the activity (Momand et al. 1992; Oliner et al. 1993) and the stability of p53 (Haupt et al. 1997; Kubbutat et al. 1997; Midgley and Lane 1997).”
Background
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citation
Cell Cycle Checkpoints: Preventing an Identity Crisis
Elledge, S. J. (1996) · Science · doi:10.1126/science.274.5293.1664 · Cited by 2,050
Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53
Canman, C. E., Lim, D.-S., Cimprich, K. A., Taya, Y., Tamai, K., Sakaguchi, K., Appella, E., Kastan, M. B., & Siliciano, J. D. (1998) · Science · doi:10.1126/science.281.5383.1677 · Cited by 2,042
Self-citation
Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage
Banin, S., Moyal, L., Shieh, S.-Y., Taya, Y., Anderson, C. W., Chessa, L., Smorodinsky, N. I., Prives, C., Reiss, Y., Shiloh, Y., et al. (1998) · Science · doi:10.1126/science.281.5383.1674 · Cited by 1,797
Self-citation
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474

Flagged first, then by citations

Show all 84 references

6 of the 84 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Mayo, 1997, Mdm2 phosphorylation by DNA-dependent protein kinase prevents ineraction with p53., Cancer Res., 57, 5013

Sorted by citations

Items 401–500 of 964

Determination of substrate specificity and putative substrates of Chk2 kinase
Seo, G., Kim, S.-E., Lee, Y.-M., Lee, J., Lee, J.-R., Hahn, M., & Kim, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00589-8 · Cited by 55
Tumor suppressor p53 cross-talks with TRIM family proteins
Liu, J., Zhang, C., Wang, X., Hu, W., & Feng, Z. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.07.003 · Cited by 57
Hyperoxia activates the ATR-Chk1 pathway and phosphorylates p53 at multiple sites
Das, K. C., & Ravi, D. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00203.2002 · Cited by 55
C-Abl as a modulator of p53
Levav-Cohen, Y., Goldberg, Z., Zuckerman, V., Grossman, T., Haupt, S., & Haupt, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.152 · Cited by 57
Selective Inactivation of p53 Facilitates Mouse Epithelial Tumor Progression without Chromosomal Instability
Lu, X., Magrane, G., Yin, C., Louis, D. N., Gray, J. W., & Dyke, T. V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.6017-6030.2001 · Cited by 55
Reactive oxygen species-evoked genotoxic stress mediates arsenic-induced suppression of male germ cell proliferation and decline in sperm quality
Zhang, X., Wang, B., Xu, S., Wang, J., Gao, L., Song, Y., Lv, J.-W., Xu, F., Li, J., Chen, J., et al. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124768 · Cited by 54
DNA damage-induced phosphorylation of p53 at serine 20 correlates with p21 and Mdm-2 induction in vivo
Jabbur, J. R., Huang, P., & Zhang, W. (2000) · Oncogene · doi:10.1038/sj.onc.1204017 · Cited by 60
Constitutively active DNA damage checkpoint pathways as the driving force for the high frequency of p53 mutations in human cancer
Halazonetis, T. D. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.03.036 · Cited by 53
The CHEK2*1100delC Allelic Variant and Risk of Breast Cancer: Screening Results from the Breast Cancer Family Registry
Bernstein, J. L., Teraoka, S. N., John, E. M., Andrulis, I. L., Knight, J. A., Lapinski, R. H., Olson, E. R., Wolitzer, A. L., Seminara, D., Whittemore, A. S., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0557 · Cited by 54
Multiple Signaling Pathways Involving ATMPreprint
Kastan, M., Lim, D., KIM, S.-T., Xu, B., & Canman, C. E. (2000) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2000.65.521 · Cited by 53
The Transcription Factor E4F1 Coordinates CHK1-Dependent Checkpoint and Mitochondrial Functions
Rodier, G., Kirsh, O., Baraibar, M. A., Houlès, T., Lacroix, M., Delpech, H., Hatchi, E., Arnould, S., Séverac, D., Dubois, E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.03.024 · Cited by 52
Deciphering the PTM codes of the tumor suppressor p53
Wen, J., & Wang, D. (2021) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjab047 · Cited by 55
The MDM2 Ubiquitination Signal in the DNA-Binding Domain of p53 Forms a Docking Site for Calcium Calmodulin Kinase Superfamily Members
Craig, A. L., Chrystal, J. A., Fraser, J. A., Sphyris, N., Lin, Y., Harrison, B. J., Scott, M. T., Dornreiter, I., & Hupp, T. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01595-06 · Cited by 52
A new effector pathway links ATM kinase with the DNA damage response
Demonacos, C., Krstic–Demonacos, M., Smith, L. M., Xu, D., O’Connor, D. P., Jansson, M., & Thangue, N. B. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1170 · Cited by 53
ATM dependent apoptosis in the nervous system
Lee, Y., & McKinnon, P. J. (2000) · APOPTOSIS · doi:10.1023/a:1009637512917 · Cited by 53
Molecular Anatomy of the DNA Damage and Replication Checkpoints
Qin, J., & Li, L. (2003) · Radiation Research · doi:10.1667/0033-7587(2003)159[0139:maotdd]2.0.co;2 · Cited by 52
Mutational Analysis of the p53 Core Domain L1 Loop
Zupnick, A., & Prives, C. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603387200 · Cited by 51
Self-citation
Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival
Sadagopan, S., Veettil, M. V., Chakraborty, S., Sharma-Walia, N., Paudel, N., Bottero, V., & Chandran, B. (2012) · Oncogene · doi:10.1038/onc.2011.648 · Cited by 53
DNA damage‐induced CHK1 autophosphorylation at Ser296 is regulated by an intramolecular mechanism
Okita, N., Minato, S., 近江恵理, Tanuma, S.-I., & Higami, Y. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.048 · Cited by 51
Blocking CHK1 Expression Induces Apoptosis and Abrogates the G2 Checkpoint Mechanism
Luo, Y., Rockow-Magnone, S. K., Kroeger, P. E., Frost, L., Chen, Z., Han, E. K.-H., Ng, S., Simmer, R. L., & Giranda, V. L. (2001) · Neoplasia · doi:10.1038/sj.neo.7900175 · Cited by 51
Reduced p53 in peripheral blood mononuclear cells from patients with rheumatoid arthritis is associated with loss of radiation‐induced apoptosis
Maas, K. H., Westfall, M. D., Pietenpol, J. A., Olsen, N. J., & Aune, T. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20931 · Cited by 51
Rad53 Checkpoint Kinase Phosphorylation Site Preference Identified in the Swi6 Protein of Saccharomyces cerevisiae
Sidorova, J. M., & Breeden, L. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3405-3416.2003 · Cited by 51
DNA Damage during the Spindle-Assembly Checkpoint Degrades CDC25A, Inhibits Cyclin–CDC2 Complexes, and Reverses Cells to Interphase
Chow, J. P. H., Siu, W. Y., Fung, T. K., Chan, W. M., Lau, A. W. S., Arooz, T., Ng, C.-P., Yamashita, K., & Poon, R. Y. C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-03-0168 · Cited by 51
Genes and Longevity of Lifespan
Bin-Jumah, M. N., Nadeem, M. S., Gilani, S. J., Al-Abbasi, F. A., Ullah, I., Alzarea, S. I., Ghoneim, M. M., Alshehri, S., Ud-Din, A., Murtaza, B. N., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031499 · Cited by 52
Phage-peptide Display Identifies the Interferon-responsive, Death-activated Protein Kinase Family as a Novel Modifier of MDM2 and p21WAF1
Burch, L. R., Scott, M. T., Pöhler, E., Meek, D. W., & Hupp, T. R. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.10.081 · Cited by 50
Trip12 is an E3 ubiquitin ligase for USP 7/ HAUSP involved in the DNA damage response
Liu, X., Yang, X., Li, Y., Zhao, S., Li, C., Ma, P., & Mao, B. (2016) · FEBS Letters · doi:10.1002/1873-3468.12471 · Cited by 54
Breast Cancer Susceptibility and the DNA Damage Response
Đapic, V., Carvalho, M. A., & Monteiro, Á. N. A. (2005) · Cancer Control · doi:10.1177/107327480501200210 · Cited by 49
Cell cycle control, DNA damage checkpoints and cancer
Laiho, M., & Latonen, L. (2003) · Annals of Medicine · doi:10.1080/07853890310014605 · Cited by 51
High-throughput measurement of the Tp53 response to anticancer drugs and random compounds using a stably integrated Tp53-responsive luciferase reporter
Sohn, T. A., Bansal, R. K., Su, G. H., Murphy, K. M., & Kern, S. E. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.949 · Cited by 49
The Werner syndrome protein contributes to induction of p53 by DNA damage
Blander, G., Zalle, N., Martínez-Leal, J. F., Bar‐Or, R. L., Yu, C., & Oren, M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0171fje · Cited by 49
Pharmacological Targeting of Senescence with Senolytics as a New Therapeutic Strategy for Neurodegeneration
Richardson, M., & Richardson, D. R. (2023) · Molecular Pharmacology · doi:10.1124/molpharm.123.000803 · Cited by 48
Early Events in the DNA Damage Response
Ward, I. M., & Chen, J. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)63001-8 · Cited by 50
p53 protects from replication-associated DNA double-strand breaks in mammalian cells
Kumari, A. R., Schultz, N., & Helleday, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207379 · Cited by 48
Casein Kinase 1α Regulates an MDMX Intramolecular Interaction To Stimulate p53 Binding
Wu, S., Chen, L., Becker, A., Schönbrunn, E., & Chen, J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00851-12 · Cited by 48
Intrinsic Kinase Activity and SQ/TQ Domain of Chk2 Kinase as Well as N-terminal Domain of Wip1 Phosphatase Are Required for Regulation of Chk2 by Wip1
Yoda, A., Xu, X. Z., Onishi, N., Toyoshima, K., Fujimoto, H., Kato, N., Oishi, I., Kondo, T., & Minami, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600403200 · Cited by 48
Murine Protein Serine-threonine Kinase 38 Activates p53 Function through Ser15 Phosphorylation
Seong, H., & Ha, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347757 · Cited by 48
The cell cycle checkpoint kinase CHK2 mediates DNA damage-induced stabilization of TTK/hMps1
Yeh, Y.-H., Huang, Y.-F., Lin, T.-Y., & Shieh, S.-Y. (2009) · Oncogene · doi:10.1038/onc.2008.477 · Cited by 47
Self-citation
Therapeutic targeting of the BCL6 oncogene for diffuse large B-cell lymphomas
Parekh, S. S., Privé, G. G., & Melnick, A. M. (2008) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190801895345 · Cited by 48
Phosphoproteins in Stress-Induced Disease
Dalton, L. E., Healey, E., Irving, J. A., & Marciniak, S. J. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396456-4.00003-1 · Cited by 49
Arsenic trioxide induces ROS activity and DNA damage, leading to G0/G1 extension in skin fibroblasts through the ATM-ATR-associated Chk pathway
Chayapong, J., Madhyastha, H., Madhyastha, R., Nurrahmah, Q. I., Nakajima, Y., Choijookhuu, N., Hishikawa, Y., & Maruyama, M. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-016-8215-7 · Cited by 47
p53 and RAD9, the DNA Damage Response, and Regulation of Transcription Networks
Lieberman, H. B., Panigrahi, S. K., Hopkins, K. M., Wang, L., & Broustas, C. G. (2017) · Radiation Research · doi:10.1667/rr003cc.1 · Cited by 47
Negative Regulation of Chk2 Expression by p53 Is Dependent on the CCAAT-binding Transcription Factor NF-Y
Matsui, T., Katsuno, Y., Inoue, T., Fujita, F., Joh, T., Niida, H., Murakami, H., Itoh, M., & Nakanishi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403232200 · Cited by 47
Radiosensitization in prostate cancer: mechanisms and targets
Palacios, D. A., Miyake, M., & Rosser, C. J. (2013) · BMC Urology · doi:10.1186/1471-2490-13-4 · Cited by 47
Posttranslational phosphorylation of mutant p53 protein in tumor development
Matsumoto, M., Furihata, M., & Ohtsuki, Y. (2006) · Medical Molecular Morphology · doi:10.1007/s00795-006-0320-0 · Cited by 47
Regulation of cyclin‐dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage‐induced neuronal death
Lee, J., & Kim, K. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20899 · Cited by 49
Role of cell cycle regulators in adipose tissue and whole body energy homeostasis
López‐Mejía, I. C., Castillo‐Armengol, J., Lagarrigue, S., & Lluis Fajas, A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2668-9 · Cited by 45
The Cytoprotective Aminothiol WR1065 Activates p53 through a Non-genotoxic Signaling Pathway Involving c-Jun N-terminal Kinase
Pluquet, O., North, S., Bhoumik, A., DIMAS, K. S., Ronai, Z. A., & Hainaut, P. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207396200 · Cited by 45
Global Analysis of Phosphorylation of Tau by the Checkpoint Kinases Chk1 and Chk2 in vitro
Mendoza, J., Sekiya, M., Taniguchi, T., Iijima, K., Wang, R., & Ando, K. (2013) · Journal of Proteome Research · doi:10.1021/pr400008f · Cited by 45
A Central Role for CK1 in Catalyzing Phosphorylation of the p53 Transactivation Domain at Serine 20 after HHV-6B Viral Infection
MacLaine, N. J., Øster, B., Bundgaard, B. B., Fraser, J. A., Buckner, C., Lazo, P. A., Meek, D. W., Höllsberg, P., & Hupp, T. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804433200 · Cited by 44
DisruptingTP53 in mouse models of human cancers
Parant, J. M., & Lozano, G. (2003) · Human Mutation · doi:10.1002/humu.10186 · Cited by 47
Mdm-2 binding and TAFII31 recruitment is regulated by hydrogen bond disruption between the p53 residues Thr18 and Asp21
Jabbur, J. R., Tabor, A., Cheng, X., Wang, H., Uesugi, M., Lozano, G., & Zhang, W. (2002) · Oncogene · doi:10.1038/sj.onc.1205856 · Cited by 46
Photodynamic therapy induced cell cycle arrest and cancer cell synchronization: review
Moloudi, K., Abrahamse, H., & George, B. P. A. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1225694 · Cited by 45
Regulation of Chk2 Ubiquitination and Signaling through Autophosphorylation of Serine 379
Lovly, C. M., Yan, L., Ryan, C. E., Takada, S., & Piwnica-Worms, H. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00821-08 · Cited by 42
Less-well known functions of cyclin/CDK complexes
Palmer, N., & Kaldis, P. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.003 · Cited by 44
FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15
Li, N., Lorenzi, F., Kalakouti, E., Normatova, M., Babaei‐Jadidi, R., Tomlinson, I. P. M., & Nateri, A. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3284 · Cited by 44
Impaired tissue growth is mediated by checkpoint kinase 1 (CHK1) in the integrated stress response
Malzer, E., Daly, M., Moloney, A. M., Sendall, T. J., Thomas, S. E., Ryder, E. J., Ryoo, H. D., Crowther, D. C., Lomas, D. A., & Marciniak, S. J. (2010) · Journal of Cell Science · doi:10.1242/jcs.070078 · Cited by 45
Antitumor Activity of Americanin A Isolated from the Seeds of Phytolacca americana by Regulating the ATM/ATR Signaling Pathway and the Skp2–p27 Axis in Human Colon Cancer Cells
Jung, C., Hong, J., Bae, S. Y., Kang, S. S., Park, H. J., & Lee, S. K. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00743 · Cited by 44
La catastrophe mitotique : un cas particulier d’apoptose
Castedo, M., & Kroemer, G. (2004) · Journal de la Société de Biologie · doi:10.1051/jbio/2004198020097 · Cited by 46
ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven
Wang, J., Wiltshire, T. D., Wang, Y., Mikell, C., Burks, J., Cunningham, C., Laar, E. S. V., Waters, S. J., Reed, E., & Wang, W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400015200 · Cited by 44
Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals
kConFab Investigators, Jekimovs, C., Chen, X., Arnold, J. M., Gatei, M. H., Richard, D. J., Spurdle, A. B., Khanna, K. K., & Chenevix‐Trench, G. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602381 · Cited by 43
p300 Does Not Require Its Acetylase Activity to Stimulate p73 Function
Zeng, X., Lee, H., Zhang, Q., & Lu, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000722200 · Cited by 46
Ataxia Telangiectasia-mutated Protein Can Regulate p53 and Neuronal Death Independent of Chk2 in Response to DNA Damage
Keramaris, E., Hirao, A., Slack, R. S., Mak, T. W., & Park, D. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304049200 · Cited by 43
SOG 1‐dependent NAC 103 modulates the DNA damage response as a transcriptional regulator in Arabidopsis
Ryu, T. H., Go, Y. S., Choi, S. H., Kim, J., Chung, B. Y., & Kim, J. (2018) · The Plant Journal · doi:10.1111/tpj.14201 · Cited by 42
ATM and Genome Maintenance: Defining Its Role in Breast Cancer Susceptibility
Khanna, K. K., & Chenevix‐Trench, G. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/b:jomg.0000048772.92326.a1 · Cited by 43
p21CDKN1A allows the repair of replication-mediated DNA double-strand breaks induced by topoisomerase I and is inactivated by the checkpoint kinase inhibitor 7-hydroxystaurosporine
Furuta, T., Hayward, R. L., Meng, L.-H., Takemura, H., Aune, G. J., Bonner, W. M., Aladjem, M. I., Kohn, K. W., & Pommier, Y. G. (2005) · Oncogene · doi:10.1038/sj.onc.1209313 · Cited by 44
Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer
Bártková, J., Guldberg, P., Grønbæk, K., Koed, K., Primdahl, H., Møller, K., Lukas, J., Orntoft, T. F., & Bártek, J. (2004) · Oncogene · doi:10.1038/sj.onc.1207878 · Cited by 43
Repression of Cyclin B1 Expression after Treatment with Adriamycin, but Not Cisplatin in Human Lung Cancer A549 Cells
Dan, S., & Yamori, T. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.4231 · Cited by 42
Chk1 Instability Is Coupled to Mitotic Cell Death of p53-deficient Cells in Response to Virus-induced DNA Damage Signaling
Jurvansuu, J., Fragkos, M., Ingemarsdotter, C. K., & Beard, P. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.06.077 · Cited by 42
Stress-induced senescence in mesenchymal stem cells: Triggers, hallmarks, and current rejuvenation approaches
Lee, S. S., Vũ, T. T., Weiss, A. S., & Yeo, G. C. (2023) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2023.151331 · Cited by 43
p53 Requires the Stress Sensor USF1 to Direct Appropriate Cell Fate Decision
Bouafia, A., Corre, S., Gilot, D., Mouchet, N., Prince, S., & Galibert, M. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004309 · Cited by 45
Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study
Lee, H. J., Srinivasan, D., Coomber, D., Lane, D. P., & Verma, C. S. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4923 · Cited by 41
Linkage Disequilibrium Mapping of CHEK2: Common Variation and Breast Cancer Risk
Einarsdóttir, K., Humphreys, K., Bonnard, C., Palmgren, J., Iles, M. M., Sjölander, A., Li, Y., Chia, K. S., Liu, E. T., Hall, P. N., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030168 · Cited by 41
Cell-type-specific role of CHK2 in mediating DNA damage-induced G2 cell cycle arrest
van Jaarsveld, M. T. M., Deng, D., Ordoñez‐Rueda, D., Paulsen, M. S., Wiemer, E. A. C., & Zi, Z. (2020) · Oncogenesis · doi:10.1038/s41389-020-0219-y · Cited by 40
2α-Hydroxyalantolactone from Pulicaria undulata: activity against multidrug-resistant tumor cells and modes of action
Hegazy, M. F., Dawood, M., Mahmoud, N., Elbadawi, M., Sugimoto, Y., Klauck, S. M., Mohamed, N. S., & Efferth, T. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153409 · Cited by 40
Refolding and structural characterization of the human p53 tumor suppressor protein
Bell, S. J., Hansen, S., & Büchner, J. (2002) · Biophysical Chemistry · doi:10.1016/s0301-4622(02)00011-x · Cited by 40
Chk2 deficiency in Myc overexpressing lymphoma cells elicits a synergistic lethal response in combination with PARP inhibition
Höglund, A., Strömvall, K., Li, Y., Forshell, L. P., & Nilsson, J. A. (2011) · Cell Cycle · doi:10.4161/cc.10.20.17887 · Cited by 39
DNA-dependent Protein Kinase and Checkpoint Kinase 2 Synergistically Activate a Latent Population of p53 upon DNA Damage
Jack, M. T., Woo, R. A., Motoyama, N., Takai, H., & Lee, P. W. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309917200 · Cited by 39
BRCA1 and Tip60 determine the cellular response to ultraviolet irradiation through distinct pathways
Kranz, D., Dohmesen, C., & Dobbelstein, M. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200712014 · Cited by 39
Multifunctional Role of ATM/Tel1 Kinase in Genome Stability: From the DNA Damage Response to Telomere Maintenance
Domenico, E. G. D., Romano, E., Porto, P. D., & Ascenzioni, F. (2014) · BioMed Research International · doi:10.1155/2014/787404 · Cited by 39
Regulation of p53 by ING family members in suppression of tumor initiation and progression
Jafarnejad, S. M., & Li, G. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9329-5 · Cited by 40
Gene expression profiling assigns CHEK2 1100delC breast cancers to the luminal intrinsic subtypes
Nagel, J. H. A., Peeters, J. K., Smid, M., Sieuwerts, A. M., Wasielewski, M., de Weerd, V., Trapman-Jansen, A., van den Ouweland, A., Brüggenwirth, H. T., van IJcken, W. F. J., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1588-x · Cited by 39
Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein
Liu, W.-L., Midgley, C., Stephen, C. W., Saville, M. K., & Lane, D. P. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5082 · Cited by 38
Loss of ATM sensitizes against O6-methylguanine triggered apoptosis, SCEs and chromosomal aberrations
Dębiak, M., Nikolova, T., & Kaina, B. (2004) · DNA repair · doi:10.1016/j.dnarep.2003.11.013 · Cited by 39
p53 activates G1 checkpoint following DNA damage by doxorubicin during transient mitotic arrest
Hyun, S., & Jang, Y. (2014) · Oncotarget · doi:10.18632/oncotarget.3103 · Cited by 38
Homeostatic control of polo-like kinase-1 engenders non-genetic heterogeneity in G2 checkpoint fidelity and timing
Liang, H., Esposito, A., De, S., Ber, S., Collin, P. J. L., Surana, U., & Venkitaraman, A. R. (2014) · Nature Communications · doi:10.1038/ncomms5048 · Cited by 37
Dying to Survive—The p53 Paradox
Lees, A., Sessler, T., & McDade, S. S. (2021) · Cancers · doi:10.3390/cancers13133257 · Cited by 38
p21 response to DNA damage induced by genistein and etoposide in human lung cancer cells
Ding, H., Duan, W., Zhu, W., Ju, R., Srinivasan, K., Otterson, G. A., & Villalona-Calero, M. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00873-8 · Cited by 37
Human T-cell Leukemia Virus Type 1 Tax Oncoprotein Prevents DNA Damage-induced Chromatin Egress of Hyperphosphorylated Chk2
Gupta, S. K., Guo, X., Durkin, S. S., Fryrear, K. A., Ward, M. D., & Semmes, O. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704110200 · Cited by 39
Response to DNA damage: why do we need to focus on protein phosphatases?
Shimada, M., & Nakanishi, M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00008 · Cited by 38
The destruction box of human Geminin is critical for proliferation and tumor growth in human colon cancer cells
Yoshida, K., Oyaizu, N., Dutta, A., & Inoue, I. (2004) · Oncogene · doi:10.1038/sj.onc.1206987 · Cited by 37
Stem Cells: The Pursuit of Genomic Stability
Wyles, S. P., Brandt, E. B., & Nelson, T. J. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151120948 · Cited by 36
A protein phosphatase feedback mechanism regulates the basal phosphorylation of Chk2 kinase in the absence of DNA damage
Carlessi, L., Buscemi, G., Fontanella, E., & Delia, D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.06.002 · Cited by 36
Negative auto-regulators trap p53 in their web
Zhou, X. Y., Cao, B., & Lu, H. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx001 · Cited by 37
Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy
Meyer, A. A., Dörk, T., Sohn, C., Karstens, J. H., & Bremer, M. (2007) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.12.002 · Cited by 36
Study of the cytolethal distending toxin (CDT)‐activated cell cycle checkpoint
Alby, F., Mazars, R., de Rycke, J., Guillou, E., Baldin, V., Darbon, J.-M., & Ducommun, B. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02205-0 · Cited by 38
Correction: Phosphorylation of Daxx by ATM Contributes to DNA Damage-Induced p53 Activation
Tang, J., Agrawal, T., Cheng, Q., Qu, L., Brewer, M. D., Chen, J., & Yang, X. (2013) · PLoS ONE · doi:10.1371/annotation/032b026d-5bcf-4c1b-aa15-65c226a53818 · Cited by 36
Alterations of G1‐S checkpoint in chordoma
Naka, T., Boltze, C., Kuester, D., Schulz, T., Schneider‐Stock, R., Kellner, A., Samii, A., Herold, C., Ostertag, H., & Roessner, A. (2005) · Cancer · doi:10.1002/cncr.21296 · Cited by 35
Battle Against Cancer: An Everlasting Saga of p53
Hao, Q., & Cho, W. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151222109 · Cited by 38
Synthesis of imidazo[2,1-b][1,3,4]thiadiazole–chalcones as apoptosis inducing anticancer agents
Kamal, Ä., Reddy, V. S., Karnewar, S., Kumar, G. B., Shaik, A. B., Mahesh, R., Chourasiya, S. S., Sayeed, I. B., & Kotamraju, S. (2014) · MedChemComm · doi:10.1039/c4md00228h · Cited by 35
p53 and MDM2 are regulated by PI-3-kinases on multiple levels under stress induced by UV radiation and proteasome dysfunction
Latonen, L., Kurki, S., Pitkänen, K., & Laiho, M. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00044-x · Cited by 37

Authors: Shieh, S.-Y., Ahn, J., Tamai, K., Taya, Y., & Prives, C.
Affiliations: Seisen University (JP)
ORCID: Shieh, Sheau-Yann
Tamai, Katsuyuki
Prives, Carol
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 2000-02-01
Volume: 14
Issue: 3
Pages: 289-300
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.14.3.289
PMC: PMC316358
OpenAlex: W2120921507
Cited by: 972
References: 84
Citations by year: 2026: 11 · 2025: 4 · 2024: 15 · 2023: 22 · 2022: 21 · 2021: 21 · 2020: 28 · 2019: 26 · 2018: 22 · 2017: 19 · 2016: 22 · 2015: 24 · 2014: 39 · 2013: 38 · 2012: 42
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Princess Takamatsu Cancer Research Fund
National Institutes of Health (CA58316)
National Cancer Institute (R37CA058316, R01CA058316, CA 58316)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
Keywords: p53 phosphorylation, Chk1, Chk2, checkpoint kinase, DNA damage response, p53 oligomerization, p53 stabilization, Schizosaccharomyces pombe, kinase activity
MeSH terms: Checkpoint Kinase 1, DNA Damage, HeLa Cells, Humans, Phosphorylation, Protein Kinases, Recombinant Proteins, Blotting, Western, Tumor Suppressor Protein p53, Protein Serine-Threonine Kinases, Protein Structure, Tertiary, Schizosaccharomyces pombe Proteins, Checkpoint Kinase 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks